Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Gilbert

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Pharmaceutical Patent Analyst|October 8, 2014
Recent advances in irreversible kinase inhibitorsAdam M Gilbert
Chemical Society Reviews|April 19, 2022
Translational PK-PD for targeted protein degradationDerek W Bartlett, Adam M Gilbert
Journal of Pharmacokinetics and Pharmacodynamics|October 22, 2020
A kinetic proofreading model for bispecific protein degradersDerek W Bartlett, Adam M Gilbert
Organic Letters|September 9, 2005
Expedient parallel synthesis of 2-amino-4-heteroarylpyrimidinesMatthew G Bursavich, Sabrina Lombardi, Adam M Gilbert
Chemical Research in Toxicology|October 30, 2013
Benchmarking in vitro covalent binding burden as a tool to assess potential toxicity caused by nonspecific covalent binding of covalent drugsUpendra P Dahal, R Scott Obach, Adam M Gilbert
Expert Opinion on Therapeutic Patents|November 30, 2010
Advances in the development of novel aggrecanase inhibitorsAdam M Gilbert, Jack A Bikker, Steven V O'Neil
Bioorganic & Medicinal Chemistry Letters|July 8, 2018
Inducing protein-protein interactions with molecular gluesYe Che, Adam M Gilbert, Veerabahu Shanmugasundaram, et al.
Nature Chemical Biology|May 17, 2015
Know your target, know your moleculeMark E Bunnage, Adam M Gilbert, Lyn H Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2008
N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)Adam M Gilbert, Matthew G Bursavich, Sabrina Lombardi, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2007
5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5Adam M Gilbert, Matthew G Bursavich, Sabrina Lombardi, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Pharmaceutical Patent Analyst|October 8, 2014
Recent advances in irreversible kinase inhibitorsAdam M Gilbert
Chemical Society Reviews|April 19, 2022
Translational PK-PD for targeted protein degradationDerek W Bartlett, Adam M Gilbert
Journal of Pharmacokinetics and Pharmacodynamics|October 22, 2020
A kinetic proofreading model for bispecific protein degradersDerek W Bartlett, Adam M Gilbert
Organic Letters|September 9, 2005
Expedient parallel synthesis of 2-amino-4-heteroarylpyrimidinesMatthew G Bursavich, Sabrina Lombardi, Adam M Gilbert
Chemical Research in Toxicology|October 30, 2013
Benchmarking in vitro covalent binding burden as a tool to assess potential toxicity caused by nonspecific covalent binding of covalent drugsUpendra P Dahal, R Scott Obach, Adam M Gilbert
Expert Opinion on Therapeutic Patents|November 30, 2010
Advances in the development of novel aggrecanase inhibitorsAdam M Gilbert, Jack A Bikker, Steven V O'Neil
Bioorganic & Medicinal Chemistry Letters|July 8, 2018
Inducing protein-protein interactions with molecular gluesYe Che, Adam M Gilbert, Veerabahu Shanmugasundaram, et al.
Nature Chemical Biology|May 17, 2015
Know your target, know your moleculeMark E Bunnage, Adam M Gilbert, Lyn H Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2008
N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)Adam M Gilbert, Matthew G Bursavich, Sabrina Lombardi, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2007
5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5Adam M Gilbert, Matthew G Bursavich, Sabrina Lombardi, et al.
Pageof 5